Načítá se...
Pharmacological Interventions for Treatment of Sarcopenia: Current Status of Drug Development for Sarcopenia
Sarcopenia, the loss of skeletal muscle mass and function with age, was first recognized as a disease in the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) (M62.84) and has recently attracted attention as aged populations increase. However, the diagnostic...
Uloženo v:
| Vydáno v: | Ann Geriatr Med Res |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean Geriatrics Society
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7370765/ https://ncbi.nlm.nih.gov/pubmed/32743297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4235/agmr.19.0028 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|